Late Breaking Abstract - Pharmacological inhibition of Epac1 protects against pulmonary fibrosis by blocking FoxO3a neddylation
Lahouaria Hadri(Icahn School of Medicine at Mount Sinai), Frank Lezoualc’h(Inserm), Jordi Ochando(Tisch Cancer Institute), Malik Bisserier(New York Medical College), Karina Formoso(Pontificia Universidad Católica Argentina), Irene C. Turnbull(Icahn School of Medicine at Mount Sinai), Steeve Provencher(Institut universitaire de cardiologie et de pneumologie de Québec), Sébastien Bonnet(Institut universitaire de cardiologie et de pneumologie de Québec), Leticia Pérez‐Rodríguez(Icahn School of Medicine at Mount Sinai), Sarah‐Eve Lemay(SNC-Lavalin (Canada)), Javier Milara(Universitat Jaume I), Sandra Breuils‐Bonnet, Mélanie Sauvaget(Canadian Heart Research Centre), M. F. Ochoa(New York Medical College), Vineeta Jagana(New York Medical College), Daniel Lozano-Ojalvo(Icahn School of Medicine at Mount Sinai), Shihong Zhang(Icahn School of Medicine at Mount Sinai), Julio Cortijo(Centre for Biomedical Network Research on Rare Diseases)
Cited by 0
Related Papers
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth
|Cancer Cell|2007|1.5k
Trained immunity, tolerance, priming and differentiation: distinct immunological processes
|Nature Immunology|2020|591
Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke
|Thorax|2013|335
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
|International Journal of Molecular Sciences|2019|312